Nyxoah Ownership | Who Owns Nyxoah?
Nyxoah Ownership Summary
Nyxoah is owned by 10.37% institutional investors, 41.73% insiders, and 47.90% retail investors. Vestal point capital, lp is the largest institutional shareholder, holding 3.75% of NYXH shares. Fidelity Select Pharmaceuticals Port is the top mutual fund, with 1.28% of its assets in Nyxoah shares.
NYXH Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Nyxoah | 10.37% | 41.73% | 47.90% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Medical Instruments & Supplies Stocks | 56.90% | 14.82% | 28.28% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vestal point capital, lp | 1.40M | 3.75% | $10.49M |
| Blackrock funding, inc. /de | 779.69K | 2.08% | $5.83M |
| Rossmore private capital | 117.94K | 0.32% | $892.85K |
| Kovack advisors | 57.83K | 0.15% | $432.55K |
| Sio capital management | 50.84K | 0.14% | $380.28K |
| Ikarian capital | 50.63K | 0.14% | $378.69K |
| Shay capital | 50.00K | 0.13% | $374.00K |
| Dekabank deutsche girozentrale | 26.20K | 0.07% | $196.00K |
| Walleye capital | 15.68K | 0.04% | $117.29K |
| Boothbay fund management | 14.74K | 0.04% | $110.28K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Vestal point capital, lp | 1.40M | 0.55% | $10.49M |
| Sio capital management | 50.84K | 0.15% | $380.28K |
| Rossmore private capital | 117.94K | 0.10% | $892.85K |
| Ikarian capital | 50.63K | 0.07% | $378.69K |
| Shay capital | 50.00K | 0.04% | $374.00K |
| Kovack advisors | 57.83K | 0.04% | $432.55K |
| Boothbay fund management | 14.74K | 0.00% | $110.28K |
| Ghp investment advisors | 2.59K | 0.00% | $19.37K |
| Walleye capital | 15.68K | 0.00% | $117.29K |
| Dekabank deutsche girozentrale | 26.20K | 0.00% | $196.00K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ikarian capital | 50.63K | 0.07% | 50.63K |
| Shay capital | 50.00K | 0.04% | 50.00K |
| Kovack advisors | 57.83K | 0.04% | 34.53K |
| Balyasny asset management | 11.28K | 0.00% | 11.28K |
| Raymond james financial | 9.41K | - | 9.41K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vestal point capital, lp | 1.40M | 0.55% | -916.95K |
| Blackrock funding, inc. /de | 779.69K | 0.00% | -281.84K |
| Renaissance | - | - | -12.20K |
| Cantor fitzgerald, l. p. | - | - | -10.00K |
| Jpmorgan chase | - | - | -301.00 |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ikarian capital | 50.63K | 0.07% | 50.63K | $378.69K |
| Shay capital | 50.00K | 0.04% | 50.00K | $374.00K |
| Balyasny asset management | 11.28K | 0.00% | 11.28K | $84.38K |
| Raymond james financial | 9.41K | - | 9.41K | $70.38K |
| Ghp investment advisors | 2.59K | 0.00% | 2.59K | $19.37K |
Sold Out
| Holder | Change |
|---|---|
| Advisor group | -300.00 |
| Jpmorgan chase | -301.00 |
| Cantor fitzgerald, l. p. | -10.00K |
| Renaissance | -12.20K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 29 | 11.54% | 3,879,854 | -35.15% | 10 | 4.06% | 16 | 45.45% | 6 | -25.00% |
| Mar 31, 2025 | 26 | 18.18% | 5,982,518 | -11.73% | 15 | 3.73% | 11 | -15.38% | 8 | 60.00% |
| Dec 31, 2024 | 22 | 10.00% | 6,777,412 | 65.02% | 20 | 14.50% | 13 | 62.50% | 5 | 66.67% |
| Sep 30, 2024 | 20 | - | 4,107,120 | -2.10% | 11 | 6.42% | 8 | -38.46% | 3 | - |
| Jun 30, 2024 | 20 | 5.26% | 4,195,054 | 92.44% | 13 | 23.61% | 13 | 8.33% | - | -100.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Select Pharmaceuticals Port | 479.06K | 1.28% | 23.55K |
| BNP Paribas B Pension Sust Bal Classic | 453.04K | 1.21% | - |
| Fidelity Small Cap Growth | 452.66K | 1.21% | - |
| BNP Paribas B Pension Bal Classic | 424.76K | 1.13% | - |
| BlackRock Health Sciences Opps Inv A | 392.84K | 1.05% | - |
| APO Medical Opportunities R | 340.00K | 0.91% | - |
| Putnam U.S. Core Equity Concentrated | 282.46K | 0.82% | - |
| Putnam Core Equity Fund Y | 282.46K | 0.82% | - |
| BlackRock Health Sciences Term Trust | 254.30K | 0.68% | -281.93K |
| Fidelity Small Cap Growth K6 | 226.93K | 0.60% | - |
NYXH Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools